Abstract
Background: The aim of this study is to assess the efficacy of tranexamic acid (1 gm) and ethamsylate (1 gm) in reducing blood loss in patients undergoing LSCS at high risk for postpartum hemorrhage. Methods: This clinical trial was conducted at El Galaa Maternity Teaching Hospital. The study included 64 women who were at high risk of postpartum hemorrhage. Results: There was significant statistical difference in the vital data before and after placental delivery between the two groups. Group 1 (the case group) This group consists of 32 patients received 1gm Tranexamic acid and 1gm Ethamsylate Intravenous slowly in the 2 minutes.- Group 2 (the control group):This group consists of 32 patient received a placebo plus the routine prophylaxis intravenous 10 IU Oxytocin in the 2 minutes Conclusion: The use of tranexamic acid and ethamsylate in cases of cesarean section is effective as a prophylaxis against post-partum hemorrhage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
